Proteomic analysis of formalin-fixed, paraffin-embedded lung neuroendocrine tumor samples from hospital archives

Journal of Proteomics

Volumn 74, Issue 3, 2011, Pages 359-370

  Tanca, Alessandro ^a,b   Addis, Maria Filippa ^a   Pagnozzi, Daniela ^a   Cossu Rocca, Paolo ^b   Tonelli, Roberto ^a   Falchi, Giovanni ^a,c   Eccher, Albino ^d   Roggio, Tonina ^a   Fanciulli, Giuseppe ^b   Uzzau, Sergio ^a,b  

^a Porto Conte Ricerche Srl   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c Biosistema Scrl   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

Author keywords

FFPE; GeLC MS MS; Lung neuroendocrine tumors; Spectral counting; Stathmin

Indexed keywords

CHROMOGRANIN A; PARAFFIN; STATHMIN;

ARTICLE; CARCINOID; CLINICAL ARTICLE; COMPUTER PROGRAM; HOMEOSTASIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG PARENCHYMA; LUNG SMALL CELL CANCER; LUNG TUMOR; MASS SPECTROMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RNA PROCESSING;

CHROMATOGRAPHY, LIQUID; FORMALDEHYDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOSPITALS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MASS SPECTROMETRY; NEUROENDOCRINE TUMORS; PARAFFIN; PARAFFIN EMBEDDING; PROTEINS; PROTEOMICS; SOFTWARE; TUMOR MARKERS, BIOLOGICAL;

EID: 78651516681     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2010.12.001     Document Type: Article

References (68)

1. Fox C., Johnson F., Whiting J., Roller P. Formaldehyde fixation. J Histochem Cytochem 1985, 33:845-853.
2. Blonder J., Veenstra T.D. Clinical proteomic applications of formalin-fixed paraffin-embedded tissues. Clin Lab Med 2009, 29:101-113.
3. Hood B.L. Proteomic analysis of formalin-fixed prostate cancer tissue. Mol Cell Proteomics 2005, 4:1741-1753.
4. Shi S.R. Protein extraction from formalin-fixed, paraffin-embedded tissue sections: quality evaluation by mass spectrometry. J Histochem Cytochem 2006, 54:739-743.
5. Sprung R.W., Brock J.W.C., Tanksley J.P., Li M., Washington M.K., Slebos R.J.C., et al. Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis. Mol Cell Proteomics 2009, 8:1988-1998.
6. Kawamura T., Nomura M., Tojo H., Fujii K., Hamasaki H., Mikami S., et al. Proteomic analysis of laser-microdissected paraffin-embedded tissues: (1) stage-related protein candidates upon non-metastatic lung adenocarcinoma. J Proteomics 2010, 73:1089-1099.
7. Ostasiewicz P., Zielinska D.F., Mann M., Wisśniewski J.R. Proteome, phosphoproteome, and n-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry. J Proteome Res 2010, 9:3688-3700.
8. DeSouza L.V., Krakovska O., Darfler M.M., Krizman D.B., Romaschin A.D., Colgan T.J., et al. mTRAQ-based quantification of potential endometrial carcinoma biomarkers from archived formalin-fixed paraffin-embedded tissues. Proteomics 2010, 10:3108-3116.
9. Addis M.F., Tanca A., Pagnozzi D., Crobu S., Fanciulli G., Cossu-Rocca P., et al. Generation of high-quality protein extracts from formalin-fixed, paraffin-embedded tissues. Proteomics 2009, 9:3815-3823.
10. Addis M.F., Tanca A., Pagnozzi D., Rocca S., Uzzau S. 2-D PAGE and MS analysis of proteins from formalin-fixed, paraffin-embedded tissues. Proteomics 2009, 9:4329-4339.
11. Gustafsson B.I., Kidd M., Chan A., Malfertheiner M.V., Modlin I.M. Bronchopulmonary neuroendocrine tumors. Cancer 2008, 113:5-21.
12. Beasley M.B., Brambilla E., Travis W.D. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol 2005, 40:90-97.
13. Pelosi G., Rodriguez J., Viale G., Rosai J. Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients. Am J Surg Pathol 2005, 29:179-187.
14. Anbazhagan R., Tihan T., Bornman D.M., Johnston J.C., Saltz J.H., Weigering A., et al. Classification of small cell lung cancer and pulmonary carcinoid by gene expression profiles. Cancer Res 1999, 59:5119-5122.
15. Bhattacharjee A. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci 2001, 98:13790-13795.
16. Virtanen C. Integrated classification of lung tumors and cell lines by expression profiling. Proc Natl Acad Sci 2002, 99:12357-12362.
17. Pedersen N., Mortensen S., Sorensen S.B., Pedersen M.W., Rieneck K., Bovin L.F., et al. Transcriptional gene expression profiling of small cell lung cancer cells. Cancer Res 2003, 63:1943-1953.
18. Jones M., Virtanen C., Honjoh D., Miyoshi T., Satoh Y., Okumura S., et al. Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles. Lancet 2004, 363:775-781.
19. Taniwaki M., Daigo Y., Ishikawa N., Takano A., Tsunoda T., Yasui W., et al. Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer. Int J Oncol 2006, 29:567-575.
20. Okubo C., Minami Y., Tanaka R., Uchihara T., Anami Y., Furuya S., et al. Analysis of differentially expressed genes in neuroendocrine carcinomas of the lung. J Thorac Oncol 2006, 1:780-786.
21. Cho N.H., Koh E.S., Lee D.W., Kim H., Choi Y.P., Cho S.H., et al. Comparative proteomics of pulmonary tumors with neuroendocrine differentiation. J Proteome Res 2006, 5:643-650.
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
23. Westermeier R. Sensitive, quantitative, and fast modifications for Coomassie Blue staining of polyacrylamide gels. Proteomics 2006, 6(Suppl 2):61-64.
24. Dupierris V., Masselon C., Court M., Kieffer-Jaquinod S., Bruley C. A toolbox for validation of mass spectrometry peptides identification and generation of database: IRMa. Bioinformatics 2009, 25:1980-1981.
25. Ishihama Y., Oda Y., Tabata T., Sato T., Nagasu T., Rappsilber J., et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 2005, 4:1265-1272.
26. Old W.M., Meyer-Arendt K., Aveline-Wolf L., Pierce K.G., Mendoza A., Sevinsky J.R., et al. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell Proteomics 2005, 4:1487-1502.
27. Zybailov B., Mosley A.L., Sardiu M.E., Coleman M.K., Florens L., Washburn M.P. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J Proteome Res 2006, 5:2339-2347.
28. Huang da W., Sherman B.T., Zheng X., Yang J., Imamichi T., Stephens R., et al. Extracting biological meaning from large gene lists with DAVID. Curr Protoc Bioinformatics 2009, Chapter 13:Unit 13 1.
29. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003, 4:P3.
30. Pham T.V., Piersma S.R., Warmoes M., Jimenez C.R. On the beta-binomial model for analysis of spectral count data in label-free tandem mass spectrometry-based proteomics. Bioinformatics 2010, 26:363-369.
31. Schirle M. Profiling core proteomes of human cell lines by one-dimensional page and liquid chromatography-tandem mass spectrometry. Mol Cell Proteomics 2003, 2:1297-1305.
32. Fang Y., Robinson D.P., Foster L.J. Quantitative analysis of proteome coverage and recovery rates for upstream fractionation methods in proteomics. J Proteome Res 2010, 9:1902-1912.
33. Piersma S.R., Fiedler U., Span S., Lingnau A., Pham T.V., Hoffmann S., et al. Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum. J Proteome Res 2010, 9:1913-1922.
34. Wu H.-Y., Chang Y.-H., Chang Y.-C., Liao P.-C. Proteomics analysis of nasopharyngeal carcinoma cell secretome using a hollow fiber culture system and mass spectrometry. J Proteome Res 2009, 8:380-389.
35. Hood B.L., Conrads T.P., Veenstra T.D. Mass spectrometric analysis of formalin-fixed paraffin-embedded tissue: unlocking the proteome within. Proteomics 2006, 6:4106-4114.
36. Azimzadeh O., Barjaktarovic Z., Aubele M., Calzada-Wack J., Sarioglu H., Atkinson M.J., et al. Formalin-fixed paraffin-embedded (FFPE) proteome analysis using gel-free and gel-based proteomics. J Proteome Res 2010, 9:4710-4720.
37. Xu H., Yang L., Wang W., Shi S.-R., Liu C., Liu Y., et al. Antigen retrieval for proteomic characterization of formalin-fixed and paraffin-embedded tissues. J Proteome Res 2008, 7:1098-1108.
38. Rahimi F., Shepherd C.E., Halliday G.M., Geczy C.L., Raftery M.J. Antigen-epitope retrieval to facilitate proteomic analysis of formalin-fixed archival brain tissue. Anal Chem 2006, 78:7216-7221.
39. Elias J.E., Haas W., Faherty B.K., Gygi S.P. Comparative evaluation of mass spectrometry platforms used in large-scale proteomics investigations. Nat Meth 2005, 2:667-675.
40. Alcolea M.P., Kleiner O., Cutillas P.R. Increased confidence in large-scale phosphoproteomics data by complementary mass spectrometric techniques and matching of phosphopeptide data sets. J Proteome Res 2009, 8:3808-3815.
41. Wang H., Chang-Wong T., Tang H.Y., Speicher D.W. Comparison of extensive protein fractionation and repetitive LC-MS/MS analyses on depth of analysis for complex proteomes. J Proteome Res 2010, 9:1032-1040.
42. Tabb D.L., Vega-Montoto L., Rudnick P.A., Variyath A.M., Ham A.J., Bunk D.M., et al. Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry. J Proteome Res 2010, 9:761-776.
43. Piersma S.R., Broxterman H.J., Kapci M., de Haas R.R., Hoekman K., Verheul H.M.W., et al. Proteomics of the TRAP-induced platelet releasate. J Proteomics 2009, 72:91-109.
44. Liu H., Sadygov R.G., Yates J.R. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 2004, 76:4193-4201.
45. Gao B.B., Stuart L., Feener E.P. Label-free quantitative analysis of one-dimensional PAGE LC/MS/MS proteome: application on angiotensin II-stimulated smooth muscle cells secretome. Mol Cell Proteomics 2008, 7:2399-2409.
46. Lundgren D.H., Hwang S.I., Wu L., Han D.K. Role of spectral counting in quantitative proteomics. Expert Rev Proteomics 2010, 7:39-53.
47. Saydam O., Senol O., Schaaij-Visser T.B., Pham T.V., Piersma S.R., Stemmer-Rachamimov A.O., et al. Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas. J Proteome Res 2010, 9:485-494.
48. Seregni E., Ferrari L., Bajetta E., Martinetti A., Bombardieri E. Clinical significance of blood chromogranin A measurement in neuroendocrine tumours. Ann Oncol 2001, 12(Suppl 2):S69-S72.
49. Said J.W., Vimadalal S., Nash G., Shintaku I.P., Heusser R.C., Sassoon A.F., et al. Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors. Hum Pathol 1985, 16:236-240.
50. Taupenot L., Harper K.L., O'Connor D.T. The chromogranin-secretogranin family. N Engl J Med 2003, 348:1134-1149.
51. Orr D.F., Chen T., Johnsen A.H., Chalk R., Buchanan K.D., Sloan J.M., et al. The spectrum of endogenous human chromogranin A-derived peptides identified using a modified proteomic strategy. Proteomics 2002, 2:1586-1600.
52. 2+/calmodulin-dependent kinase IV/Gr-dependent phosphorylation of oncoprotein 18. Mol Cell Biol 1997, 17:3459-3467.
53. Roos G., Brattsand G., Landberg G., Marklund U., Gullberg M. Expression of oncoprotein 18 in human leukemias and lymphomas. Leukemia 1993, 7:1538-1546.
54. Polzin R.G., Benlhabib H., Trepel J., Herrera J.E. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M. Gene 2004, 341:209-218.
55. Brattsand G. Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors. Br J Cancer 2000, 83:311-318.
56. Singer S., Ehemann V., Brauckhoff A., Keith M., Vreden S., Schirmacher P., et al. Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis. Hepatology 2007, 46:759-768.
57. Chen G., Wang H., Gharib T.G., Huang C.C., Thomas D.G., Shedden K.A., et al. Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas. Mol Cell Proteomics 2003, 2:107-116.
58. Sadow P.M., Rumilla K.M., Erickson L.A., Lloyd R.V. Stathmin expression in pheochromocytomas, paragangliomas, and in other endocrine tumors. Endocr Pathol 2008, 19:97-103.
59. Hatakeyama S., Sugihara K., Nakayama J., Akama T.O., Wong S.M., Kawashima H., et al. Identification of mRNA splicing factors as the endothelial receptor for carbohydrate-dependent lung colonization of cancer cells. Proc Natl Acad Sci USA 2009, 106:3095-3100.
60. Zhang B., Wang Y., Su Y. Peroxiredoxins, a novel target in cancer radiotherapy. Cancer Lett 2009, 286:154-160.
61. Kinnula V.L., Pääkkö P., Soini Y. Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung. FEBS Lett 2004, 569:1-6.
62. Rhee S., Chae H., Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 2005, 38:1543-1552.
63. Manevich Y., Fisher A.B. Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism?. Free Radic Biol Med 2005, 38:1422-1432.
64. Svensk A.M., Soini Y., Paakko P., Hiravikoski P., Kinnula V.L. Differential expression of superoxide dismutases in lung cancer. Am J Clin Pathol 2004, 122:395-404.
65. Kinnula V.L., Crapo J.D. Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med 2003, 167:1600-1619.
66. Rho J.H., Roehrl M.H., Wang J.Y. Tissue proteomics reveals differential and compartment-specific expression of the homologs transgelin and transgelin-2 in lung adenocarcinoma and its stroma. J Proteome Res 2009, 8:5610-5618.
67. Assinder S., Stanton J., Prasad P. Transgelin: an actin-binding protein and tumour suppressor. Int J Biochem Cell Biol 2009, 41:482-486.
68. Huang Q., Chen W., Wang L., Lin W., Lin J., Lin X. Identification of transgelin as a potential novel biomarker for gastric adenocarcinoma based on proteomics technology. J Cancer Res Clin Oncol 2008, 134:1219-1227.